A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis:results of a European LeukemiaNet (ELN) consensus process

Autoria(s): Barosi, Giovanni; Birgegard, Gunnar; Finazzi, Guido; Griesshammer, Martin; Harrison, Claire; Hasselbalch, Hans; Kiladijan, Jean-Jacques; Lengfelder, Eva; Mesa, Ruben; McMullin, Mary Frances; Passamonti, Francesco; Reilly, John T; Vannucchi, Alessandro M; Barbui, Tiziano; McMullin, Mary
Data(s)

01/03/2010
Identificador

http://pure.qub.ac.uk/portal/en/publications/a-unified-definition-of-clinical-resistance-and-intolerance-to-hydroxycarbamide-in-polycythaemia-vera-and-primary-myelofibrosis(6517d76c-da77-4408-89fe-78eb359caca8).html

http://dx.doi.org/10.1111/j.1365-2141.2009.08019.x
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Barosi , G , Birgegard , G , Finazzi , G , Griesshammer , M , Harrison , C , Hasselbalch , H , Kiladijan , J-J , Lengfelder , E , Mesa , R , McMullin , M F , Passamonti , F , Reilly , J T , Vannucchi , A M , Barbui , T & McMullin , M 2010 , ' A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis : results of a European LeukemiaNet (ELN) consensus process ' British Journal of Haematology , vol 148 , no. 6 , pp. 961-3 . DOI: 10.1111/j.1365-2141.2009.08019.x
Palavras-Chave #Antineoplastic Agents #Consensus Development Conferences as Topic #Drug Resistance #Humans #Hydroxyurea #Polycythemia Vera #Primary Myelofibrosis #Terminology as Topic
Tipo

article
Acesso ao item digital